Terrassa, Spain

María Montserrat Contijoch-Llobet

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Laboratorios Del Dr. Esteve S.a.. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: María Montserrat Contijoch-Llobet. Retrieved from https://idiyas.com/inventor/maría-montserrat-contijoch-llobet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of María Montserrat Contijoch-Llobet

Introduction

María Montserrat Contijoch-Llobet is a notable inventor based in Terrasa, Spain. He has made significant contributions to the field of pharmacology, particularly through his work on sigma receptor inhibitors. His innovative approach has led to advancements in the treatment of diseases associated with the sigma receptor.

Latest Patents

Contijoch-Llobet holds 1 patent for his invention related to sigma receptor inhibitors. The patent describes compounds of formula (I) that exhibit pharmacological activity towards the sigma receptor. It also details the processes for preparing these compounds, the pharmaceutical compositions that include them, and their potential use in treating or preventing diseases linked to the sigma receptor.

Career Highlights

He is currently associated with Laboratorios del Dr. Esteve S.A., where he continues to contribute to pharmaceutical research and development. His work has been instrumental in advancing the understanding of sigma receptors and their implications in various medical conditions.

Collaborations

Contijoch-Llobet has collaborated with notable colleagues, including Christian Laggner and María Rosa Cuberes-Altisent. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

María Montserrat Contijoch-Llobet's contributions to pharmacology through his patent on sigma receptor inhibitors exemplify the impact of innovative thinking in medicine. His work continues to pave the way for new therapeutic approaches.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…